Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer
- PMID: 24138885
- DOI: 10.1016/j.immuni.2013.10.003
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer
Abstract
The complex interactions between tumors and their microenvironment remain to be elucidated. Combining large-scale approaches, we examined the spatio-temporal dynamics of 28 different immune cell types (immunome) infiltrating tumors. We found that the immune infiltrate composition changed at each tumor stage and that particular cells had a major impact on survival. Densities of T follicular helper (Tfh) cells and innate cells increased, whereas most T cell densities decreased along with tumor progression. The number of B cells, which are key players in the core immune network and are associated with prolonged survival, increased at a late stage and showed a dual effect on recurrence and tumor progression. The immune control relevance was demonstrated in three endoscopic orthotopic colon-cancer mouse models. Genomic instability of the chemokine CXCL13 was a mechanism associated with Tfh and B cell infiltration. CXCL13 and IL21 were pivotal factors for the Tfh/B cell axis correlating with survival. This integrative study reveals the immune landscape in human colorectal cancer and the major hallmarks of the microenvironment associated with tumor progression and recurrence.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment in
-
A "big data" view of the tumor "immunome".Immunity. 2013 Oct 17;39(4):631-2. doi: 10.1016/j.immuni.2013.10.002. Immunity. 2013. PMID: 24138879 Free PMC article.
Similar articles
-
A "big data" view of the tumor "immunome".Immunity. 2013 Oct 17;39(4):631-2. doi: 10.1016/j.immuni.2013.10.002. Immunity. 2013. PMID: 24138879 Free PMC article.
-
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.Cancer Res. 2011 Feb 15;71(4):1263-71. doi: 10.1158/0008-5472.CAN-10-2907. Epub 2011 Feb 8. Cancer Res. 2011. PMID: 21303976
-
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.Clin Cancer Res. 2013 Aug 1;19(15):4079-91. doi: 10.1158/1078-0432.CCR-12-3847. Epub 2013 Jun 19. Clin Cancer Res. 2013. PMID: 23785047
-
Duality of B Cell-CXCL13 Axis in Tumor Immunology.Front Immunol. 2020 Oct 21;11:521110. doi: 10.3389/fimmu.2020.521110. eCollection 2020. Front Immunol. 2020. PMID: 33193299 Free PMC article. Review.
-
The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.Eur J Surg Oncol. 2012 Oct;38(10):889-96. doi: 10.1016/j.ejso.2012.05.011. Epub 2012 Jun 19. Eur J Surg Oncol. 2012. PMID: 22721580 Review.
Cited by
-
Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link.Int J Colorectal Dis. 2024 Oct 28;39(1):173. doi: 10.1007/s00384-024-04748-y. Int J Colorectal Dis. 2024. PMID: 39465427 Free PMC article. Review.
-
Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis.J Transl Med. 2021 Apr 26;19(1):174. doi: 10.1186/s12967-021-02834-1. J Transl Med. 2021. PMID: 33902636 Free PMC article.
-
Multidimensional study of cell division cycle-associated proteins with prognostic value in gastric carcinoma.Bosn J Basic Med Sci. 2022 Feb 1;22(1):64-76. doi: 10.17305/bjbms.2021.5783. Bosn J Basic Med Sci. 2022. PMID: 34082692 Free PMC article.
-
mtPCDI: a machine learning-based prognostic model for prostate cancer recurrence.Front Genet. 2024 Sep 4;15:1430565. doi: 10.3389/fgene.2024.1430565. eCollection 2024. Front Genet. 2024. PMID: 39296545 Free PMC article.
-
Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma.Front Chem. 2022 Sep 6;10:847621. doi: 10.3389/fchem.2022.847621. eCollection 2022. Front Chem. 2022. PMID: 36147250 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical